Roche expands hepatitis diagnostics portfolio to help clinicians diagnose and monitor patients with acute or chronic hepatitis B infection
Elecsys ® HBeAg quant is an immunoassay that can be used as an early marker of acute hepatitis B infection, as well as an indicator of chronic active hepatitis in combination with other laboratory results and clinical information.The single test will inform clinicians if treatment is required and regimens are working in conjunction with other diagnostic assays.Almost 300 million people globally have chronic hepatitis B, causing a significant burden to health systems as it puts patients at high risk of death from cirrhosis and liver cancer.1Basel, 27 November 2023 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the la...
Source: Roche Media News - November 27, 2023 Category: Pharmaceuticals Source Type: news
How Late Can You Give Routine Newborn Care?
Discussion
Routine newborn screening and treatment is focused on assisting the infant’s transition to extrauterine life, screening for health problems that may or may not be easily identifiable, and preventing acute or chronic health problems. Healthy infants begin with healthy pregnancies including risk factor assessment and screening of mothers. Such routine maternal screening and treatment does or may include glucose tolerance tests, ultrasound examinations, screenings for maternal blood type (with appropriate administration of Rho(D) immunoglobulin if appropriate), Hepatitis B, Neisseria gonorrhea, Chlamydia, Cyt...
Source: PediatricEducation.org - November 20, 2023 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news
How Late Can You Give Routine Newborn Care?
Discussion
Routine newborn screening and treatment is focused on assisting the infant’s transition to extrauterine life, screening for health problems that may or may not be easily identifiable, and preventing acute or chronic health problems. Healthy infants begin with healthy pregnancies including risk factor assessment and screening of mothers. Such routine maternal screening and treatment does or may include glucose tolerance tests, ultrasound examinations, screenings for maternal blood type (with appropriate administration of Rho(D) immunoglobulin if appropriate), Hepatitis B, Neisseria gonorrhea, Chlamydia, Cyt...
Source: PediatricEducation.org - November 20, 2023 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news
Cutting-edge therapy is the first treatment that could put liver damage from cirrhosis in reverse
The cutting-edge therapy is the first to treat cirrhosis, the scarring of liver tissue caused by heavy drinking, fatty diets and long-term infections from the viruses hepatitis B and C. (Source: the Mail online | Health)
Source: the Mail online | Health - November 18, 2023 Category: Consumer Health News Source Type: news
Ultrasound model predicts liver cancer risk
Thursday, November 30 | 2:20 p.m.-2:30 p.m. | R6-SSGI19-6 | Room E352A model integrating clinical and surveillance ultrasound features for patients at high risk of hepatocellular carcinoma will be presented in this session.In his talk, Yeun-Yoon Kim, MD, from Yonsei University in South Korea will present research that demonstrates how this model has superior performance compared with previously reported risk scoring systems in this area.Predicting risk for hepatocellular carcinoma would help with triaging and strategizing best treatment options. Models integrating ultrasound features are being developed to help with suc...
Source: AuntMinnie.com Headlines - November 14, 2023 Category: Radiology Authors: Amerigo Allegretto Tags: 2023 Ultrasound Preview Source Type: news
Features found on MRI may predict liver cancer recurrence after surgery
An algorithm based on MRI features could help clinicians predict liver cancer recurrence after patients have undergone liver resection, researchers have found.
The findings could translate into better patient outcomes, wrote a team led by Hanyu Jiang, PhD, of West China Hospital, Sichuan University, in Chengdu, China. The study results were published November 7 in Radiology.
"Identifying patients at high risk for advanced-stage hepatocellular carcinoma recurrence after liver resection may improve patient survival," the group noted.
Liver resection is a common treatment for hepatocellular carcinoma, but its long-term eff...
Source: AuntMinnie.com Headlines - November 8, 2023 Category: Radiology Authors: Kate Madden Yee Tags: Clinical News Imaging Informatics MRI Artificial Intelligence Genitourinary Radiology Source Type: news
EXCLISIVE: Ocean Biomedical's JV Partner Virion Therapeutics Dosed First Patients In Novel Immunotherapy Study For Chronic Hepatitis B
Ocean Biomedical, Inc. OCEA announces that its joint venture partner, Virion Therapeutics, has dosed its first patient in the Phase 1b clinical trial of its investigational VRON-0200 immunotherapy. Virion Therapeutics is a clinical-stage biotechnology company developing novel T cell-based…#oceanbiomedical #ocea #viriontherapeutics #virion #hongkong #newzealand #suecurrie #cooofvirion #vron0200 #jonathankurtis (Source: Reuters: Health)
Source: Reuters: Health - October 26, 2023 Category: Consumer Health News Source Type: news
Africa: 91 Million People Living With Hepatitis B and C in Africa - Govt
[Daily Trust] Coordinating Minister of Health and Social Welfare, Prof. Muhammad Ali Pate, says a total of 91 million people are living with chronic hepatitis in Africa. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - October 25, 2023 Category: African Health Tags: Africa Health and Medicine Nigeria West Africa Source Type: news
Wistar spinoff Virion forms joint venture to accelerate development of potential hepatitis B cure
Virion was recently awarded a Pennsylvania Academic Innovation Zone grant to support the relocation of the company to B+labs at Cira Center in Philadelphia. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - October 12, 2023 Category: Pharmaceuticals Authors: John George Source Type: news
Ocean Biomedical partners to bring hepatitis B drug to human trials
The goal of the new joint venture is to develop treatments for cancer and infectious diseases using T cell-based immunotherapies. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - October 12, 2023 Category: Pharmaceuticals Authors: Mary Serreze Source Type: news
How COVID-19 Changed Life for People Terrified of Needles
From the moment COVID-19 reached pandemic designation, Joe McDougall had nightmares. Not, like others, about the potential path of the virus, but about the seemingly inevitable moment at which he’d be asked—or held down and forced—to receive a vaccine. McDougall, now 39, is terrified of needles and a global pandemic meant that for the first time since adolescence, he might not be able to avoid them.
[time-brightcove not-tgx=”true”]
Of all of the challenges facing mass COVID-19 vaccination, fear of needles is one of the least acknowledged by public-health campaigns. Even what we know ...
Source: TIME: Health - October 12, 2023 Category: Consumer Health News Authors: Haley Weiss Tags: Uncategorized healthscienceclimate Source Type: news
Nigeria: Kano Mass Wedding - Intending Couples Test Positive for Hepatitis B, HIV, Pregnancy
[Vanguard] Some intending couples for the Kano mass wedding scheduled to be held soon have already tested positive for Hepatitis B, HIV, sickle cell and pregnancy. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - October 7, 2023 Category: African Health Tags: HIV-Aids and STDs Health and Medicine Nigeria Pregnancy and Childbirth West Africa Source Type: news
Should you pick Novavax ’s COVID-19 shot over mRNA options?
For cardiologist Eric Topol, this week’s vaccine news presented a personal dilemma. Topol, who directs the Scripps Research Translational Institute and is a popular commenter on COVID-19 research, had hoped to get an updated COVID-19 vaccine from Novavax, rather than a messenger RNA (mRNA) shot from Pfizer or Moderna. Novavax relies on an older, protein-based approach that has shown long-lasting effects against other pathogens, and Topol wondered whether it might produce more durable protection. On Tuesday, it seemed he might get his chance: a drugstore he visited for an mRNA vaccine ran out of doses, and hours later the...
Source: ScienceNOW - October 6, 2023 Category: Science Source Type: news
Revaccination Suggested for Hep B Vaccine Nonresponders After Hep C Cure
MONDAY, Sept. 18, 2023 -- Patients with chronic hepatitis C virus (HCV) who do not respond to hepatitis B virus (HBV) vaccine should undergo revaccination after HCV treatment and eradication, according to a study published online July 31 in The... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 18, 2023 Category: Pharmaceuticals Source Type: news
People Infected With Hepatitis C May Need the Hepatitis B Shot
MONDAY, Sept. 11, 2023 -- Patients with hepatitis C should consider being vaccinated again for hepatitis B, because their immune response to the initial shot may be inadequate, a new study suggests.
Researchers at the University of Minnesota Medical... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - September 11, 2023 Category: General Medicine Source Type: news
